⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aryastha Life Sciences and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Aryastha Life Sciences
↗Hyderabad, India
Aryastha Life Sciences is a contract research and development organization (CRDMO) that provides integrated drug discovery and development solutions. The company specializes in medicinal chemistry, discovery biology, preclinical services, DMPK, toxicology, and formulation development, aiming to de-risk and streamline the drug discovery process for pharmaceutical and biotech clients.
Founded in 2023, the company leverages advanced technology platforms, including patient-derived tumor organoids and iPSC-based ex vivo models, to enhance clinical translatability. Aryastha operates with a mission to accelerate the delivery of novel medicines by providing flexible, agile, and integrated R&D services.
CLASSIFICATION
SIZE & FINANCIALS
Employees:21-50
Revenue:$3M-$4M
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Series A
Investors:Vessella Group
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Vessella Group (Investor/Strategic Partner)
COMPETITION
Position:Emerging
Competitors:WuXi AppTec, Syngene International, Charles River Laboratories, Aragen Life Sciences
LEADERSHIP
Key Executives:
Raghava Reddy Kethiri - Co-Founder & CEO
Scientific Founders:Raghava Reddy Kethiri, Pradip K. Majumder
LINKS
Website:aryastha.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aryastha Life Sciences. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.